See the DrugPatentWatch profile for Zolpidem
What patent (or patents) cover zolpidem, and when do they expire?
“Zolpidem” is the active ingredient in branded insomnia drugs such as Ambien (as well as multiple generics). Patent coverage depends on the specific product form and strength (for example, immediate-release vs extended-release), and the relevant patent can be the original drug patent plus later “life-cycle” patents such as reformulations or dosing forms.
To check the most relevant, up-to-date patent status and expiry timing for zolpidem (including key filings and which patents are still listed as protecting specific products), see DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/zolpidem
Does zolpidem have different patents for Ambien vs Ambien CR?
Often, yes. Companies commonly obtain separate patent protection for different formulations (for example, immediate-release versus extended-release mechanisms, and sometimes specific release technologies or composition claims). That means expiry can differ between products even when the active ingredient is the same (zolpidem).
DrugPatentWatch.com tracks patent-by-product relationships, which is usually the fastest way to confirm which zolpidem-related patents are tied to the exact brand/formulation you mean: https://www.drugpatentwatch.com/patent/zolpidem
Is generic zolpidem already available, and can generics launch before every patent expires?
Generics typically launch only when they meet the regulatory pathway requirements (for example, based on patent listing status and exclusivity) and can be blocked while any listed, relevant patent still prevents approval for a particular product. In practice, some patents may expire earlier than others, letting certain generic versions come to market while other versions remain delayed.
For the patent/exclusivity landscape specific to zolpidem product variants, DrugPatentWatch.com provides a consolidated view: https://www.drugpatentwatch.com/patent/zolpidem
What exactly do you mean by “zolpidem paten”?
If you tell me which one you’re asking about, I can narrow it to the right patent set and dates:
- Ambien (immediate-release) or Ambien CR (extended-release)?
- A specific strength (e.g., 5 mg, 10 mg)?
- A specific country (US, EU, etc.)?
DrugPatentWatch.com’s zolpidem page is the starting point for that lookup: https://www.drugpatentwatch.com/patent/zolpidem
Sources
- DrugPatentWatch.com – zolpidem patent page